BCM
IOSP icon

BlueCrest Capital Management’s Innospec IOSP Stock Holding History

BlueCrest Capital Management’s Portfolio IOSP Stock Details IOSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,445
Closed -$204K – 740
2019
Q1 		$204K Buy
+2,445
New +$182K 0.01% 943
2015
Q4 		– Sell
-9,059
Closed -$421K – 1074
2015
Q3 		$421K Buy
+9,059
New +$415K 0.01% 630

Other funds holding IOSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BlueCrest Capital Management's IOSP Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Innospec (IOSP) in Q2 2019, closing a stake of 2,445 shares — an estimated $204K sold.

BlueCrest Capital Management first reported a position in IOSP in Q3 2015 and held it in 2 quarters. The position peaked at $421K in Q3 2015. 198 funds tracked by Wall St. Rank hold IOSP as of Q2 2019.

  • BlueCrest Capital Management reported no remaining Innospec position as of Q2 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 2,445 Innospec shares in Q2 2019, an estimated $204K.
  • BlueCrest Capital Management first reported a position in Innospec in Q3 2015 and held it in 2 quarters.
  • BlueCrest Capital Management's Innospec position peaked at $421K in Q3 2015.
  • 198 funds tracked by Wall St. Rank held Innospec as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.